'Appalled' Lundbeck appeals European Commission's pay for delay fine
This article was originally published in SRA
Executive Summary
Lundbeck is appealing against the European Commission's "erroneous" decision to fine the Danish pharmaceutical firm €93.8m for breaching competition law1. The company hopes the appeal will shed light on what it claims are "legal and factual errors" by the commission and mark an important legal precedent for other firms navigating Europe's complex patent system.